<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR27">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Park</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>IC</given-names>
   </name>
   <name>
    <surname>Bae</surname>
    <given-names>IJ</given-names>
   </name>
   <name>
    <surname>Seo</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>SH</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>SI</given-names>
   </name>
   <name>
    <surname>Eun</surname>
    <given-names>CK</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Rhee</surname>
    <given-names>CH</given-names>
   </name>
  </person-group>
  <article-title>Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor</article-title>
  <source>Int. J. Oncol.</source>
  <year>2003</year>
  <volume>22</volume>
  <issue>6</issue>
  <fpage>1271</fpage>
  <lpage>1276</lpage>
  <?supplied-pmid 12738993?>
  <pub-id pub-id-type="pmid">12738993</pub-id>
 </element-citation>
</ref>
